Verseon starts dosing in clinical trial of anti-coagulant treatment | 4 February 2019 - Stock Market Wire

Verseon starts dosing in clinical trial of anti-coagulant treatment | 4 February 2019  Stock Market Wire

StockMarketWire.com - Verseon said dosing had started in a clinical trial for its anti-coagulant treatment for the prevention of stroke and heart attack in coronary ...